Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2004 050 135.2 |
| 96 | EP file number | EAKZ | 10 00 8980.4 |
| 97 | EP publication number | EPN | 2335725 |
| 54 | Designation/title | TI | Hochkonzentrierte Antikörper- und Proteinformulierungen |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/395 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 47/18 (2006.01), A61K 47/06 (2006.01) |
| 22 | DE application date | DAT | Mar 29, 2004 |
| 96 | EP application date | EAT | Mar 29, 2004 |
| 43 | Date of first publication | OT | Jun 22, 2011 |
| Date of publication of grant | PET | Oct 12, 2016 |
| 71/73 | Applicant/owner | INH | Genentech, Inc., South San Francisco, Calif., US; Novartis AG, 4056 Basel, CH |
| 72 | Inventor | IN | Liu, Jun, Pacifica, CA 94044, US; Shire, Steven, Emerald Hills, CA 94062, US |
| 74 | Representative | VTR | Leinweber & Zimmermann Patentanwalts-PartG mbB, 80331 München, DE |
| Address for service | | Leinweber & Zimmermann Patentanwalts-PartG mbB, 80331 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
460659 P
Apr 4, 2003
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002335725
Searchable text:
EP000002335725
Original document:
EP000002335725B1
Searchable text:
EP000002335725B1 |
| 43 | Date of first publication | EVT | Jun 22, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Aug 5, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 31, 2024
(Show all update days)(Hide all update days)- Aug 5, 2011
- Date of the first transfer into DPMAregister
|
